Novartis Pharma Stein AG — FDA Facility Profile

FEI 3002653483

Novartis Pharma Stein AG is an FDA-registered facility (FEI 3002653483) located in CH-4332, CH. Registered operations: ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK. RegDataLab tracks 12 FDA inspections at this facility.

Reviewing Novartis Pharma Stein AG as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Novartis Pharma Stein AG yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

What FDA found at this site

Latest inspection
May 19, 2026: Voluntary Action Indicated (VAI)
Inspections on record
12 (8 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Import refusals
10 or more

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Showing the 10 most recent of 12 inspections. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
May 19, 2026Voluntary Action Indicated (VAI)Procedures not in writing, fully followed (21 CFR 211.22(d))
Procedures for sterile drug products (21 CFR 211.113(b))
Jul 19, 2024Voluntary Action Indicated (VAI)No citations listed
Dec 6, 2022Voluntary Action Indicated (VAI)No citations listed
Dec 4, 2018Voluntary Action Indicated (VAI)SOPs not followed / documented (21 CFR 211.100(b))
Environmental Monitoring System (21 CFR 211.42(c)(10)(iv))
Buildings not maintained in good state of repair (21 CFR 211.58)
May 9, 2017Voluntary Action Indicated (VAI)Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Procedures for sterile drug products (21 CFR 211.113(b))
Lot or control number assigned (21 CFR 211.130(c))
Quarantine Storage of Components (21 CFR 211.82(b))
and 4 more
Oct 16, 2015Voluntary Action Indicated (VAI)No citations listed
May 1, 2015No Action Indicated (NAI)No citations listed
Mar 25, 2014No Action Indicated (NAI)No citations listed
Jun 22, 2012Voluntary Action Indicated (VAI)No citations listed
Jul 2, 2010Voluntary Action Indicated (VAI)No citations listed

Facility details

Company
Novartis Pharma Stein AG
Location
CH-4332 (CH)
Registration Expires
Dec 31, 2027
Operations
ANALYSIS; API MANUFACTURE; LABEL; MANUFACTURE; PACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.